ZAP Surgical Systems, a leading company in robotic brain surgery, has achieved a major milestone by treating its 5,000th patient using the ZAP-X Gyroscopic Radiosurgery platform. This accomplishment shows that the ZAP-X technology is becoming more accepted around the world. The important case happened at Hackensack Meridian Neuroscience Institute, which is part of Jersey Shore University Medical Center in Neptune, New Jersey. The patient, Christopher Czerwinski, is a 64-year-old nurse who works in trauma and ICU. He was treated for a meningioma in the right cavernous sinus. Mr. Czerwinski first noticed double vision almost two years ago, and his symptoms got worse in April 2025 when he was on vacation at Disney World. He remembers seeing two Cinderella castles because of his condition. After talking to an ophthalmologist, he had an MRI that led to his diagnosis. At first, his symptoms were managed with prism glasses and contact lenses.
Health Technology Insights: NESA Becomes First Inpatient Virtual Care Platform Officially Listed in Epic Toolbox
Mr. Czerwinski chose Jersey Shore University Medical Center for his treatment because of the advanced ZAP-X system and the skill of the medical team. He handled the procedure well and was back to his normal activities quickly. “Stereotactic radiosurgery is changing how we treat complex brain issues,” said Dr. Shabbar F. Danish, the chair of Neurosurgery at Hackensack Meridian Neuroscience Institute and a professor at Hackensack Meridian School of Medicine. “The accuracy and flexibility of ZAP-X let us target the tumor effectively while keeping the important surrounding tissues safe. Christopher’s case shows how we can treat difficult tumors while keeping a high quality of life.”
Health Technology Insights: Reid Health Adopts AI Virtual Care in All Patient Rooms
Outside of his job in healthcare, Mr. Czerwinski likes running, playing the piano, taking photos, and working out with his wife. He thanked the medical team for their caring treatment and praised the non-invasive nature of the ZAP-X procedure. Vito Buccellato, president and chief hospital executive at Jersey Shore University Medical Center, said, “We are proud to offer this advanced procedure to our community, so patients don’t have to travel far for top care.” The ZAP-X system is a major innovation in brain radiosurgery. It uses gyroscopic beam delivery to direct radiation from many angles, focusing the treatment on the tumor while protecting healthy brain tissue and key organs like the optic nerves and brainstem. The treatment is painless, doesn’t require surgery, and is usually done in one outpatient session without anesthesia or hospital stay.
John R. Adler, founder and CEO of ZAP Surgical and Emeritus Dorothy & TK Chan Professor at Stanford University, said, “Treating our 5,000th patient is not just a number milestone, but a sign that our mission to make brain radiosurgery safer, smarter, and more available is working.” Unlike traditional radiosurgery systems that use radioactive Cobalt-60, ZAP-X uses a modern linear accelerator to produce radiation. This removes many safety and regulation issues that come with isotope-based systems. ZAP-X is also special because it doesn’t need a vault, making it easier to install in clinical settings with both inside and outside windows.
Kenneth N. Sable, president of the Acute Hospital Division at Hackensack Meridian Health, added, “We brought top specialists like Dr. Shabbar Danish and Dr. Timothy Chen to bring advanced treatments like ZAP-X to Jersey Shore and Hackensack Meridian Health. We are happy that our 5,000th ZAP-X patient is from our local community.” This milestone reflects the ongoing growth and popularity of ZAP-X as a preferred treatment for patients needing accurate, non-invasive brain radiosurgery.
Health Technology Insights: Kexing Biopharm Enters Strategic Partnership with IQVIA to Accelerate Global Expansion
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
